Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04678167

Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis

Led by University Hospital, Brest · Updated on 2026-03-19

51

Participants Needed

2

Research Sites

426 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Vestibular neuritis is a brutal and continuous dizzying syndrome of peripheral (vestibular) origin without cochlear or other associated involvement. Specifically, vestibular neuritis is inflammation of the nerve that innervates the vestibular canals (the inner ear). It is characterized by the sudden onset of intense and prolonged vertigo accompanied by postural imbalance, nausea and vomiting, without hearing impairment or other neurological symptoms. Vestibular neuritis is the second cause of peripheral vertigo after benign paroxysmal positional vertigo. It represents approximately 7% of patients consulting for vertigo. The purpose of this study is to evaluate if wearing Boarding Ring glasses can be accelerated vestibular compensation.

CONDITIONS

Official Title

Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients
  • Diagnosis of vestibular neuritis with continuous rotating vertigo and nausea
  • Presence of spontaneous horizonto-rotating nystagmus beating towards the healthy ear
  • Postural deviation towards the affected ear
  • Vestibular hyporeflexia greater than 25% measured by caloric tests
  • Provided free, informed, and written consent
Not Eligible

You will not qualify if you...

  • History of vestibular vertigo or vertigo lasting more than 4 days
  • Associated hearing loss or tinnitus
  • Motor ocular abnormalities of central origin
  • Refusal or inability to give consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

CHU de Brest

Brest, France, 29200

Actively Recruiting

2

CH Pays de Morlaix

Morlaix, France, 29672

Terminated

Loading map...

Research Team

J

Jean-Christophe LECLERE, Dr

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here